CHINA PHARMA HOLDINGS, INC. Finite-Lived Intangible Assets, Gross
CHINA PHARMA HOLDINGS, INC. (CPHI) had Finite-Lived Intangible Assets, Gross of $46.23 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2026-08-14
- 2026-06-30: Finite-Lived Intangible Assets, Gross $46.23M.
- 2026-03-31: Finite-Lived Intangible Assets, Gross $45.50M.
- 2025-12-31: Finite-Lived Intangible Assets, Gross $29.99M.
- 2025-09-30: Finite-Lived Intangible Assets, Gross $14.29M.
| Period end | Finite-Lived Intangible Assets, Gross |
|---|---|
| 2026-06-30 | $46.23M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $45.50M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $29.99M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $14.29M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $11.76M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $11.72M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $11.71M 10-K · filed 2026-04-01 |
| 2024-09-30 | $9.62M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $9.46M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $8.15M 10-K · filed 2025-03-31 |
| 2023-09-30 | $6.41M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.36M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $6.69M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $6.55M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $4.75M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.03M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $5.32M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $5.29M 10-K · filed 2023-03-30 |
| 2021-09-30 | $5.21M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $5.23M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $5.14M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $5.17M 10-K · filed 2022-03-30 |
| 2020-09-30 | $4.96M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $4.77M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $4.76M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $4.84M 10-K · filed 2021-03-26 |
| 2019-09-30 | $4.77M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $4.91M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $5.03M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $4.91M 10-K · filed 2020-03-30 |
| 2018-09-30 | $4.92M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $5.10M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $5.38M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $5.19M 10-K · filed 2019-03-28 |
| 2017-09-30 | $5.16M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $4.98M 10-Q · filed 2017-08-14 |
| 2016-12-31 | $4.86M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |